If you are a high-net-worth executive or corporate insider sitting on a large concentrated stock position, there is a good chance your financial advisor has pitched you on a prepaid variable equity collar — also known as a variable prepaid forward contract, or VPF. The pitch sounds compelling: monetize 75–90% of your stock’s value in upfront cash, defer the capital gains tax, and still keep some upside if the stock rises. It sounds like the best of all worlds.
But that pitch conceals a reality that has cost investors tens of millions of dollars in hidden fees, forfeited gains, and devastating losses. A growing body of FINRA arbitration awards — including a landmark $95.3 million award against UBS in February 2025 — reveals a troubling pattern: brokers at firms like UBS and J.P. Morgan recommend these opaque, conflicted products without adequately disclosing the risks, without presenting simpler alternatives, and without regard for whether the strategy actually serves the client’s best interest.
This article explains how prepaid variable equity collars and related equity monetization derivatives actually work, why they create a dangerous false sense of security for investors, how brokers profit at their clients’ expense, and what legal options are available when things go wrong.
What Is a Prepaid Variable Equity Collar?
A prepaid variable equity collar — technically a variable prepaid forward contract (VPF) — is an over-the-counter derivative that bundles three financial components into a single contract. The investor simultaneously enters into a long put option (which creates a “floor” price below which losses are theoretically limited), a short call option (which creates a “cap” that limits the investor’s upside participation), and a prepaid forward element (which delivers upfront cash to the investor in exchange for a future obligation to deliver shares).
Here is how it works in practice. Suppose you are an executive holding $10 million worth of your company’s stock. Your broker proposes a VPF with a floor at 90% of current value and a cap at 130%. You pledge the shares as collateral and receive an upfront, non-refundable cash payment of approximately $8 million to $8.5 million — typically 75–90% of the stock’s market value, depending on the collar width and contract terms. The contract has a maturity of two to five years.
At maturity, settlement depends on where the stock price lands relative to the floor and the cap. If the stock has fallen below the floor price, you deliver all of your pledged shares to the bank (or, if the contract permits, receive a cash-settlement and retain the shares). If the stock price is between the floor and the cap, you deliver a variable number of shares whose value equals the floor price obligation. And if the stock has risen above the cap, you deliver the minimum number of shares — but you forfeit all appreciation above the cap price. The bank, not you, captures that upside.
The settlement flexibility — physical share delivery, cash, or substitute shares — is what distinguishes a VPF from a simple forward sale. This flexibility is also what allows the transaction to avoid treatment as a taxable “constructive sale” under Internal Revenue Code Section 1259, at least when the contract is properly structured. But as several court decisions have demonstrated, the tax treatment is far from guaranteed.
How VPFs Compare to Standard Equity Collars and Exchange Funds
A standard equity collar is a simpler, more transparent structure. You buy a put option to protect against downside and sell a call option to generate premium income, but the two options are separate exchange-traded or OTC contracts. There is no upfront cash monetization built in. If you want liquidity, you take a separate margin loan against the collared position — but under Regulation T, you can only borrow up to 50% of the stock’s market value for equity reinvestment. The key advantage of a standard collar over a VPF is transparency: you can see exactly what you are paying for the put, what you are receiving for the call, and what the margin loan costs. In a VPF, all of these costs are bundled into a single opaque figure.
Exchange funds take a fundamentally different approach. Structured as limited partnerships, they allow multiple investors to contribute concentrated positions in-kind and receive partnership units representing a proportional share of a diversified pool. No capital gains tax is triggered at contribution. However, investors face a mandatory seven-year lockup, the fund must hold at least 20% of assets in illiquid qualifying assets like real estate, and there is no upfront cash liquidity. Exchange funds are designed for genuine diversification, not monetization.
Each of these strategies has legitimate uses in the right circumstances. The problem arises when brokers recommend the most complex, most expensive, and most conflicted option — the VPF — without presenting the simpler alternatives or explaining why the VPF is supposedly superior for the specific client’s situation.
The False Sense of Security: Why These Products Harm Investors
The central danger of prepaid variable equity collars is that investors believe they are hedging their concentrated stock risk when they are actually locking in losses, forfeiting upside, and paying fees they cannot see. This “false sense of security” manifests in several concrete ways.
The Collar Protects the Bank, Not You
When a bank advances 75–90% of a stock’s value upfront, the bank is the party with the most to lose if the stock collapses. The put option that creates the “floor” exists primarily to protect the bank’s advance — not to protect the investor. The investor merely receives the illusion of downside protection while surrendering the most valuable aspect of stock ownership: the right to participate in future appreciation.
Hidden Fees Consume 10–25% of Stock Value
The gap between your stock’s market value and the upfront cash payment you receive is not just an interest charge. It represents the total embedded cost of the transaction: interest on the advance, the net cost of the option premiums, the bank’s profit margin, and various structural fees — all bundled into a single, opaque number. On a $1.5 million stock position, a typical VPF advance of 85% means the investor pays approximately $225,000 in embedded costs. If those components were priced separately — as they would be in a standard collar plus margin loan — the investor could comparison-shop and negotiate each piece. Bundling eliminates that ability.
Capped Upside Eliminates the Primary Benefit of Holding Stock
With caps typically set at 120–160% of the stock’s current value, investors in volatile, high-growth stocks can forfeit enormous returns. The UBS Tesla cases from 2025 illustrate the problem vividly. When Tesla stock surged from approximately $60 to over $700 per share, any VPF cap would have surrendered the vast majority of that extraordinary gain. For investors who held concentrated positions in companies like Tesla, Nvidia, or other high-growth names, the cap effectively eliminated the one scenario that would have justified the risk of holding a concentrated position in the first place.
Rolling Costs Are Punitive When You Need Protection Most
Research by AQR Capital Management, published in The Journal of Wealth Management in 2025, found that rolling a VPF at maturity is most expensive precisely when the stock has declined significantly — the exact scenario the investor entered the VPF to protect against. This creates a structural catch-22: the strategy breaks down in the very conditions it was designed to address, and that fundamental flaw is rarely disclosed to investors at the time of purchase.
Additional Risks Brokers Fail to Disclose
Beyond these structural problems, VPFs carry counterparty credit risk (the investor depends on the issuing bank’s solvency for the full contract term), margin call risk (certain structures require additional collateral if the stock declines), early termination penalties that can be devastating, and changes in dividend tax treatment on pledged shares. J.P. Morgan’s own documentation acknowledges that the payoff on early termination will not equal the payoff an investor would expect at maturity — a disclosure that appears in the fine print but is rarely emphasized in the sales presentation.
How Brokers Profit at Your Expense
The conflicts of interest embedded in VPF transactions are severe. In most cases, the recommending firm serves simultaneously as investment advisor and as the counterparty taking the other side of the trade. The bank profits from the spread between option premiums, the embedded interest rate on the advance, stock lending income from the pledged shares (which the bank may lend to short-sellers), and hedging profits from shorting the underlying stock. When the firm also invests the VPF proceeds into its own proprietary products — as JPMorgan did in the Burford Trust case — it earns yet another layer of fees on top.
This compensation structure creates powerful incentives for brokers to recommend VPFs over simpler, cheaper alternatives. UBS’s recruitment of its Yield Enhancement Strategy team with $50 million in upfront bonuses illustrates how enormous compensation packages can drive the sale of complex products regardless of client suitability. When a firm has invested that kind of money in a product team, there is immense pressure to generate revenue to justify the expenditure.
When Are Prepaid Variable Forwards Unsuitable?
Under FINRA Rule 2111 and SEC Regulation Best Interest, brokers must have a reasonable basis for believing a recommendation is suitable for the specific customer. VPFs are broadly unsuitable for retirees or near-retirees who need income rather than tax deferral; trust accounts with restrictions on asset disposition; investors seeking capital preservation or with conservative risk tolerance; less experienced investors who do not understand derivative mechanics; and investors with short time horizons or near-term liquidity needs.
Regulation Best Interest, effective since June 2020, requires broker-dealers to satisfy four obligations when making recommendations: Disclosure, Care, Conflict of Interest, and Compliance. The Care Obligation specifically requires acting in the client’s best interest and exercising “heightened scrutiny” when recommending complex or risky products. Critically, this means brokers must evaluate and present reasonably available alternatives. A broker who recommends a VPF without seriously considering a 10b5-1 systematic selling plan, an exchange fund, direct sales with tax planning, or even a transparent standalone collar has arguably failed the Care Obligation.
FINRA’s 2026 Annual Regulatory Oversight Report, published in December 2025, continues to identify firms recommending “complex and illiquid products that are inconsistent with clients’ investment profiles” as a top examination finding. The SEC’s 2024 enforcement action against First Horizon Advisors for Reg BI compliance failures around structured products established that simply having written policies is not enough — firms must actively enforce them.
Enforcement Actions and Landmark Cases
While no SEC or FINRA enforcement action from 2023–2026 specifically targets prepaid variable forward sales practices as the primary misconduct, significant FINRA arbitration awards and court decisions provide a robust body of precedent for investors who have been harmed.
UBS / Andrew Burish — $95.3 Million FINRA Arbitration Award (February 2025)
In the second-largest customer arbitration award in FINRA history, nine members of the Hansen family alleged that UBS broker Andrew Burish recommended concentrated short positions in Tesla stock — an unsuitable, high-risk strategy for investors whose stated objectives were asset protection and multi-generational wealth transfer. The three-person FINRA panel awarded approximately $69.7 million in punitive damages on top of compensatory damages, signaling the severity of the suitability violations. UBS filed a motion to vacate in federal court in March 2025.
Blackmon v. UBS — $6.138 Million FINRA Arbitration Award (2026)
Kyle Blackmon, a Compass, Inc. real estate agent, represented by Robert Wayne Pearce, alleged that UBS failed to act in his “Best Interest” in recommending Prepaid Equity Collars. A FINRA Arbitration Panel awarded $5.375 Million in compensatory damages, pre-judgment interest and costs totaling over $6.138 Million.
Barni v. UBS — $763,868 FINRA Arbitration Award (2025)
Sean Barni, a former Tesla executive, represented by Robert Wayne Pearce, alleged UBS failed to diversify his concentrated Tesla stock position and mishandled an options collar strategy on his shares. UBS moved his assets to a fee-based account but never implemented the collar on the concentrated stock. A FINRA panel awarded $388,000 in compensatory damages plus interest, costs, and legal fees. The panel denied expungement for the involved financial advisors.
JPMorgan Chase — Burford Trust ($18.1 Million Judgment, 2012)
This is the most directly on-point VPF misconduct case in the public record. JPMorgan, serving as co-trustee of the Carolyn S. Burford Trust, sold variable prepaid forward contracts on the trust’s ExxonMobil shares between 2000 and 2005. The Oklahoma court found the VPFs were entered into shortly after a mentally impaired beneficiary became co-trustee at the bank’s suggestion. The judge found the contracts unsuitable for the trust and that JPMorgan engaged in self-dealing “double dipping” by investing VPF proceeds into its own proprietary products while charging additional trustee fees. The court ordered JPMorgan to restore 220,122 shares of ExxonMobil and characterized the evidence as overwhelmingly demonstrating the bank’s grossly negligent administration of the trust.
UBS — SEC Yield Enhancement Strategy Settlement ($25 Million, 2022)
While involving iron condor options rather than VPFs, this SEC enforcement action reveals the same institutional pattern of complex product misconduct at UBS. The SEC found that UBS marketed its Yield Enhancement Strategy to approximately 600 advisory clients with $2 billion in assets, but failed to train its financial advisors on the downside risks. Advisors could not form a reasonable basis for believing the recommendations were suitable. Estimated investor losses exceeded $1 billion. The SEC’s Complex Financial Instruments Unit emphasized that firms are obligated to ensure all parties involved in selling complex products have a clear understanding of the risks involved.
J.P. Morgan — SEC Enforcement ($151 Million, 2024)
In October 2024, the SEC charged J.P. Morgan Securities and J.P. Morgan Investment Management in five separate actions involving misleading disclosures, breach of fiduciary duty, and failure to disclose financial incentives when recommending proprietary programs. The actions revealed that J.P. Morgan grew assets in the affected programs from $10.5 billion to over $30 billion during the violation period. While not VPF-specific, this action establishes the same self-dealing pattern seen in the Burford Trust case.
A Brief Note on the Tax Risks
One of the primary selling points of a VPF is tax deferral. Because the investor delivers a variable number of shares at maturity rather than a fixed number, a properly structured VPF is not treated as a taxable “constructive sale” under IRC Section 1259. The IRS confirmed this treatment in Revenue Ruling 2003-7, provided the contract maintains adequate spread between the floor and cap prices — generally at least 20 percentage points.
But this tax treatment is far from bulletproof. In Estate of McKelvey v. Commissioner, the Second Circuit found that extending a VPF contract created a new taxable event, resulting in approximately $71 million in short-term capital gain. In Anschutz Company v. Commissioner, both the Tax Court and the Tenth Circuit held that a VPF combined with a concurrent stock lending agreement constituted a current taxable sale. These cases demonstrate that the tax deferral promised by VPF sellers can evaporate under circumstances the investor never anticipated — and the resulting tax bill can be catastrophic.
These Products Exist in a Regulatory Guidance Vacuum
After comprehensive review of FINRA regulatory notices, FINRA Annual Regulatory Oversight Reports from 2024 through 2026, SEC Examination Priorities for fiscal years 2025 and 2026, SEC investor bulletins, and SEC risk alerts, no product-specific regulatory guidance addresses prepaid variable forwards, equity collars used for monetization, or equity monetization strategies by name.
This is a significant gap. While FINRA and the SEC have issued detailed guidance on structured notes, leveraged exchange-traded products, and variable annuities, the equity monetization product category — which includes some of the most expensive and conflict-laden products sold to high-net-worth investors — operates without any targeted regulatory framework. The absence of product-specific oversight means that investors must rely entirely on general suitability rules and Reg BI’s broad requirements, which are inherently less protective than product-specific standards.
What Your Broker Should Have Recommended Instead
Simpler, more transparent alternatives exist for managing concentrated stock positions, and a broker’s failure to present them may constitute a violation of both Reg BI and FINRA suitability rules.
10b5-1 Systematic Selling Plans allow pre-scheduled, formula-driven stock sales established during open trading windows, with a 90-day cooling-off period for Section 16 officers and directors under the SEC’s 2022 amendments. These plans provide full upside participation until shares are sold, carry no counterparty risk, and impose no lockup — though they offer no tax deferral and no downside protection during the selling period.
Exchange Funds achieve genuine diversification with complete tax deferral at contribution. The trade-off is a mandatory seven-year lockup period and no upfront cash liquidity. For investors whose primary goal is diversification rather than monetization, exchange funds are often the most appropriate solution.
Charitable Remainder Trusts allow the trust to sell concentrated stock without triggering immediate capital gains, providing an income stream to the donor and a charitable deduction. These are particularly suitable for charitably inclined investors who do not need to retain full ownership of the position.
Direct Sales with Tax Planning — spreading sales across tax years, harvesting losses elsewhere in the portfolio, using direct indexing, or investing proceeds in Qualified Opportunity Zones — remain the simplest and most flexible approach. While they involve immediate tax consequences, they also eliminate counterparty risk, fee opacity, and upside forfeiture entirely.
Standalone Collars — buying a put and selling a call as separate transactions — make all component costs visible and negotiable. As CFA Institute has recommended, this approach is superior for investors who are sophisticated enough to deal with the individual components and want to see what they are actually paying.
The critical question for suitability analysis is whether the broker evaluated these alternatives and documented why the VPF was superior for the specific client’s situation. In many cases, the answer is no.
Protecting Your Rights If You Have Been Harmed
If you entered into a prepaid variable equity collar, variable prepaid forward contract, or similar equity monetization strategy and suffered losses, you may have grounds for a FINRA arbitration claim or other legal action against your broker-dealer. Common causes of action in these cases include:
Unsuitable recommendations — the broker recommended a VPF that was inconsistent with your investment objectives, risk tolerance, time horizon, or financial situation.
Failure to disclose material risks — the broker did not adequately explain the embedded fees, capped upside, rolling costs, early termination penalties, counterparty risk, or tax risks associated with the product.
Breach of fiduciary duty or Reg BI violations — the broker failed to act in your best interest by placing the firm’s compensation interests ahead of your financial well-being, or by failing to consider and present less costly alternatives.
Failure to supervise — the firm’s supervisory systems failed to catch unsuitable VPF recommendations, inadequate risk disclosures, or conflicts of interest in the sales process.
Self-dealing and conflicts of interest — the firm served as both advisor and counterparty, profiting from multiple layers of the transaction without adequate disclosure.
The $95.3 million UBS award and the $18.1 million JPMorgan Burford Trust judgment demonstrate that arbitration panels and courts are willing to impose substantial damages — including punitive damages — when they find that firms recommended unsuitable complex products or breached their duties to clients.
Contact a Securities Attorney
The Law Offices of Robert Wayne Pearce, P.A. has extensive experience representing investors in FINRA arbitration claims involving complex derivative products, concentrated stock strategies, and broker misconduct. If you or someone you know suffered losses from a prepaid variable equity collar, variable prepaid forward contract, equity collar, or other equity monetization strategy recommended by a financial advisor at UBS, J.P. Morgan, or any other brokerage firm, we want to hear from you.
For a free consultation, contact us at (561) 338-0037 or visit our case results page to learn more about the recoveries we have obtained for our clients. Time limitations apply to these claims, so prompt action is important to protect your rights.
